Find Paid Clinical Trials in Italy

Paid Clinical Trials and Focus Groups

Find Paid Clinical Trials

Paid Clinical Trials in Italy




  • Condition:   Cardiac Transplantation
    Interventions:   Drug: Everolimus;   Drug: Mycophenolate mofetil + Everolimus
    Sponsor:   Novartis
    Recruiting - verified November 2009

  • Conditions:   Hemiplegia;   Cerebral Palsy
    Interventions:   Other: action observation therapy;   Other: repetition of gestures
    Sponsors:   University of Modena and Reggio Emilia;   University of Parma
    Recruiting - verified November 2009

  • Conditions:   Heart Failure;   Exercise Tolerance
    Interventions:   Other: Rate-adaptive pacemaker programming;   Other: VVI at 40 bpm
    Sponsor:   Federico II University
    Recruiting - verified November 2009

  • Condition:   Friedreich's Ataxia
    Interventions:   Drug: Lu AA24493;   Drug: Placebo
    Sponsor:   H. Lundbeck A/S
    Recruiting - verified November 2009

  • Conditions:   Restenosis;   Tight Glycemic Control
    Interventions:   Drug: Insulin;   Drug: Insulin
    Sponsor:   Second University of Naples
    Not yet recruiting - verified November 2009

  • Conditions:   Coronary Microvascular Dysfunction;   Metabolic Syndrome;   Diabetes
    Intervention:   Other: Coronary microcirculation assessment
    Sponsor:   S.M. Misericordia Hospital
    Recruiting - verified November 2009

  • Condition:   Kidney Transplantation
    Interventions:   Drug: Cyclosporins;   Drug: Rapamycin
    Sponsor:   IRCCS Policlinico S. Matteo
    Recruiting - verified November 2009

  • Condition:   Bone Dehiscence Defects
    Intervention:   Device: Implant surgery
    Sponsor:   Institut Straumann AG
    Recruiting - verified November 2009

  • Condition:   Liver Cirrhosis
    Intervention:   Other: Human Fetal Liver Cell Transplantation
    Sponsors:   The Mediterranean Institute for Transplantation and Advanced Specialized Therapies;   UPMC;   UP
    Recruiting - verified November 2009

  • Condition:   Liver Transplantation
    Interventions:   Drug: Advagraf;   Drug: Mycophenolate Mofetil;   Drug: Basiliximab;   Drug: Corticosteroids
    Sponsor:   Astellas Pharma Inc
    Recruiting - verified November 2009

  • Condition:   Diabetes Mellitus, Type 2
    Interventions:   Drug: linagliptin;   Drug: placebo
    Sponsor:   Boehringer Ingelheim Pharmaceuticals
    Recruiting - verified November 2009

  • Condition:   Central Nervous System Lymphoma
    Interventions:   Drug: Methotrexate;   Drug: Ara-C;   Drug: Rituximab;   Drug: Thiotepa;   Radiation: radiotherapy;   Drug: BCNU;   Other: APBSCT
    Sponsor:   International Extranodal Lymphoma Study Group (IELSG)
    Active, not recruiting - verified November 2009

  • Condition:   Diffuse Large B-cell Lymphoma
    Interventions:   Drug: Rituximab;   Drug: Cyclophosphamide;   Drug: Vincristine;   Drug: Prednisone;   Drug: Doxorubicin
    Sponsor:   Fondazione Intergruppo Italiano Linfomi Onlus
    Not yet recruiting - verified November 2009

  • Condition:   Polycystic Kidney Diseases
    Interventions:   Drug: Everolimus;   Drug: Standard Therapy
    Sponsor:   A. Manzoni Hospital
    Recruiting - verified November 2009

  • Condition:   Lymphocytic Leukemia, Chronic
    Interventions:   Drug: RO5072759;   Drug: rituximab;   Drug: chlorambucil
    Sponsors:   Hoffmann-La Roche;   Genentech
    Not yet recruiting - verified November 2009

  • Conditions:   Coronary Artery Disease;   Bifurcation Lesions
    Intervention:   Procedure: Kissing DEB
    Sponsor:   Ospedale Santa Maria Goretti
    Recruiting - verified November 2009

  • Condition:   Sjögren's Syndrome
    Intervention:   Drug: LimphoStat-B
    Sponsors:   University of Udine;   Azienda Ospedaliera S. Maria della Misericordia
    Recruiting - verified November 2009

  • Condition:   Heart Failure
    Intervention:  
    Sponsor:   Cardiac Concepts, Inc.
    Recruiting - verified November 2009

  • Condition:   Rheumatoid Arthritis
    Interventions:   Drug: tocilizumab;   Drug: tocilizumab;   Drug: methotrexate
    Sponsor:   Hoffmann-La Roche
    Recruiting - verified November 2009

  • Conditions:   Arrhythmias, Cardiac;   Bradycardia;   Syncope
    Interventions:   Device: Implantable Cardioverter-Defibrillator (ICD);   Device: Implantable Pacemaker Generator (IPG);   Device: Implantable Loop Recorder (ILR);   Device: Cardiac Resynchronization Therapy-Defibrillator (CRT-D)
    Sponsor:   Medtronic Italia
    Recruiting - verified November 2009

  • Condition:   Hodgkin Lymphoma
    Intervention:  
    Sponsor:   Gruppo Italiano Studio Linfomi
    Recruiting - verified November 2009

  • Condition:   Periprocedural Myocardial Necrosis
    Intervention:   Drug: ROSUVASTATIN
    Sponsor:   University of Roma La Sapienza
    Not yet recruiting - verified November 2009

  • Condition:   Hemostasis
    Interventions:   Drug: Omni-stat Celox;   Drug: Control
    Sponsor:   Cardiochirurgia E.H.
    Not yet recruiting - verified November 2009

  • Condition:   Type 2 Diabetes Mellitus
    Interventions:   Drug: Saxagliptin;   Drug: Metformin
    Sponsors:   AstraZeneca;   Bristol-Myers Squibb
    Recruiting - verified November 2009

  • Condition:   Retinal Vein Occlusion
    Interventions:   Drug: VEGF Trap-Eye (BAY86-5321);   Other: Sham treatment
    Sponsors:   Bayer;   Regeneron Pharmaceuticals
    Recruiting - verified November 2009

  • Condition:   Travelers' Diarrhea
    Interventions:   Dietary Supplement: Protecflor;   Dietary Supplement: Placebo
    Sponsors:   Lallemand SAS;   Sprim Italy
    Not yet recruiting - verified October 2009

  • Condition:   Breast Cancer
    Interventions:   Drug: exemestane;   Drug: lapatinib
    Sponsor:   National Cancer Institute, Naples
    Not yet recruiting - verified November 2009

  • Conditions:   Coronary Artery Disease;   Angioplasty, Transluminal, Percutaneous Coronary
    Intervention:   Device: Kaname cobalt-chromium coronary stent
    Sponsor:   Terumo Europe N.V.
    Not yet recruiting - verified October 2009

  • Condition:   Hypercalciuria
    Interventions:   Behavioral: Low salt diet;   Behavioral: Water therapy alone
    Sponsors:   University of Parma;   Università Vita-Salute San Raffaele;   University of Milan;   Catholic University of the Sacred Heart
    Completed - verified October 2009

  • Condition:   Non Small Cell Lung Cancer
    Interventions:   Drug: Pemetrexed;   Drug: Cisplatin;   Drug: Bevacizumab
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • Condition:   Non Muscle Invasive Bladder Cancer
    Interventions:   Procedure: NBI TUR;   Procedure: Standard TUR
    Sponsor:   National Institute for Cancer Research, Italy
    Recruiting - verified October 2009

  • Condition:   Myocardial Reperfusion Injury
    Interventions:   Procedure: Postconditioning;   Procedure: Primary angioplasty and stenting without additional intervention
    Sponsor:   University of Padua
    Active, not recruiting - verified October 2009

  • Condition:   Detrusor Overactivity
    Intervention:   Other: ultrasonography
    Sponsor:   Università degli Studi dell'Insubria
    Completed - verified October 2009

  • Condition:   Chronic Obstructive Pulmonary Disease
    Interventions:   Drug: Aclidinium bromide;   Drug: Placebo
    Sponsors:   Almirall S.A.;   Forest Laboratories
    Recruiting - verified November 2009

  • Condition:   Non Small Cell Lung Cancer
    Interventions:   Drug: Pemetrexed;   Drug: Cisplatin;   Radiation: Thoracic Radiotherapy
    Sponsor:   Eli Lilly and Company
    Recruiting - verified November 2009

  • Condition:   Chronic Obstructive Pulmonary Disease
    Interventions:   Drug: Indacaterol;   Drug: Tiotropium
    Sponsor:   Novartis Pharmaceuticals
    Recruiting - verified October 2009
  • Find Paid Clinical Trials